Inventor · disambiguated record
Sylvain Cottens
Also filed as: COTTENS SYLVAIN
15 granted patents·14 pending applications·949 citations·filing 1990–2022
95Inventor score
Top patents by PatentIndex Score
29 records- 0198US5665772AO-alkylated rapamycin derivatives and their use, particularly as immunosuppressantsSANDOZ LTD·Filed 1993·Granted Sep 9, 1997·393 cites·10 claims
- 0296US5912253ARapamycin derivativesNOVARTIS AG·Filed 1994·Granted Jun 15, 1999·134 cites·19 claims
- 0392US5985890ARapamycin derivativesNOVARTIS AG·Filed 1996·Granted Nov 16, 1999·110 cites·7 claims
- 0490US6645970B2Indolylmaleimide derivativesNOVARTIS AG·Filed 2001·Granted Nov 11, 2003·31 cites·20 claims
- 0590US6440990B1O-alkylated rapamycin derivatives and their use, particularly as immunosuppressantsNOVARTIS AG·Filed 1997·Granted Aug 27, 2002·84 cites·35 claims
- 0690US6200985B1Rapamycin derivativesNOVARTIS AG·Filed 1999·Granted Mar 13, 2001·86 cites·18 claims
- 0776US7825124B2Indolylmaleimide derivativesALBERT RAINER·Filed 2007·Granted Nov 2, 2010·2 cites·3 claims
- 0876US6486209B2Use for 1,3-propanediol derivativesNOVARTIS AG·Filed 2001·Granted Nov 26, 2002·8 cites·25 claims
- 0975US6818638B2Melvinolin derivativesNOVARTIS AG·Filed 2002·Granted Nov 16, 2004·10 cites·12 claims
- 1075US6274629B1Use for 1,3-propanediol derivativesNOVARTIS AG·Filed 1997·Granted Aug 14, 2001·30 cites·23 claims
- 1173US6630492B1Lymphocyte function antigen-1 antagonistsNOVARTIS AG·Filed 1998·Granted Oct 7, 2003·41 cites·11 claims
- 1272US7205279B2Pharmaceutical compositionsNOVARTIS AG·Filed 2000·Granted Apr 17, 2007·2 cites·4 claims
- 1368US7786123B2Indolylmaleimide derivativesALBERT RAINER·Filed 2009·Granted Aug 31, 2010·0 cites·3 claims
- 1464US7326801B22-amino-propanol derivativesNOVARTIS AG·Filed 2002·Granted Feb 5, 2008·5 cites·4 claims
- 1564US2007208075A1Pharmaceutical compositionsCOTTENS SYLVAIN·Filed 2007·Application pending·0 cites
- 1658US5166181AHalogenoalkylphenyl-alcohols, ketones and hydrates thereofSANDOZ LTD·Filed 1990·Granted Nov 24, 1992·13 cites·13 claims
- 1749US2024294499A1Targeted protein degradation using bifunctional compounds that bind ubiquitin ligase and target mcl-1 proteinCAPTOR THERAPEUTICS S A·Filed 2022·Application pending·0 cites
- 1849US2003069315A1New use for 1,3-propanediol derivativesFiled 2002·Application pending·0 cites
- 1947US2008045530A1Organic Compounds and Their UsesBRANDL TRIXI·Filed 2007·Application pending·0 cites
- 2046US2024307547A1Novel compounds which bind to cereblon, and methods of use thereofCAPTOR THERAPEUTICS S A·Filed 2021·Application pending·0 cites
- 2146US2010204159A1Organic compounds and their usesBRANDL TRIXL·Filed 2007·Application pending·0 cites
- 2245US2007142475A1Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides and use as renin inhibitorsSELLNER HOLGER·Filed 2004·Application pending·0 cites
- 2344US2024294489A1Low molecular weight protein degraders and their applicationsCAPTOR THERAPEUTICS S A·Filed 2021·Application pending·0 cites
- 2444US2007265281A1Organic Compounds and Their UsesCOTTENS SYLVAIN·Filed 2007·Application pending·0 cites
- 2544US2010240638A1Organic Compounds and their usesBRITT SHAWN D·Filed 2008·Application pending·0 cites
- 2642US2024343706A1Piperidine-2,6-dione derivatives which bind to cereblon, and methods of use thereofCAPTOR THERAPEUTICS S A·Filed 2020·Application pending·0 cites
- 2742US2023065745A1Piperidine-2,6-dione derivatives which bind to cereblon, and methods of use thereofCAPTOR THERAPEUTICS S A·Filed 2020·Application pending·0 cites
- 2842US2002037895A1Mevinolin derivativesFiled 2001·Application pending·0 cites
- 2941US2010087427A1Pyrrolidine derivatives for the treatment of a disease depending on the activity of reninBREITENSTEIN WERNER·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sylvain Cottens files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →